Cristin Rothfuss - 03 Sep 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
EVP, General Counsel
Signature
/s/ Cristin Rothfuss
Issuer symbol
SRPT
Transactions as of
03 Sep 2025
Transactions value $
$0
Form type
4
Filing time
05 Sep 2025, 21:30:03 UTC
Previous filing
11 Mar 2025
Next filing
02 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rothfuss Cristin EVP, General Counsel 215 FIRST STREET, CAMBRIDGE /s/ Cristin Rothfuss 05 Sep 2025 0002046214

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Award $0 +93.9K +444.69% $0.00 115K 03 Sep 2025 Direct F1
transaction SRPT Common Stock Award $0 +25K +21.74% $0.00 140K 03 Sep 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company.
F2 The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board.